<p>Acurx Pharmaceuticals Inc. announced that its stockholders have approved an amendment to the company’s Certificate of Incorporation, increasing the total number of authorized shares of common stock from 200 million to 250 million. The amendment was filed with the Secretary of State of Delaware and took effect immediately. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acurx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-092166), on September 22, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

ACXP

<p>Acurx Pharmaceuticals Inc. has received approval from its stockholders to amend its Certificate of Incorporation, increasing the total number of authorized shares of common stock from 200 million to 250 million. This amendment has been filed with the Secretary of State of Delaware and is effective immediately.</p>

Acurx Pharmaceuticals Increases Authorized Shares to 250 Million